Background Over the past 18 years neuromodulation therapies have gained support as
treatments for faecal incontinence (FI); sacral nerve stimulation (SNS) is the most …

Abstract Purpose of Review To review the epidemiology, pathogenesis, clinical features,
and management of primary constipation and fecal incontinence in the elderly. Recent …

Aims Sacral neuromodulation (SNM) is an accepted therapy for a variety of conditions.
However, despite over 20 years of experience, it remains a specialized procedure with a …

Abstract Aim In Europe during the last decade sacral nerve stimulation (SNS) or sacral
neuromodulation (SNM) has been used to treat faecal incontinence (FI) and constipation …

Aim Sacral nerve stimulation (SNS) reduces incontinence episodes and improves the quality
of life of patients treated for faecal incontinence. However, the exact mechanism of action of …

OBJECTIVES: The objective of this study was to show that although transcutaneous
electrical tibial nerve stimulation (TENS) is being increasingly used to treat fecal …

The severity of fecal incontinence widely varies and can have dramatic devastating impacts
on a person's life. Fecal incontinence is common, though it is often under-reported by …

Faecal incontinence, defined as the involuntary loss of solid or liquid stool, is a common
problem affecting 0.8–8.3% of the adult population. Individuals suffering from faecal …

Objective: The aim of this study was to evaluate the efficacy of intrasphincteric injections of
autologous myoblasts (AMs) in fecal incontinence (FI) in a controlled study. Summary of …

Objective: This study aimed to evaluate the outcome of sacral nerve stimulation (SNS) for
fecal incontinence at 5 years after implantation and to identify predictors of sustained …